XRTXXORTX Therapeutics Inc.$1.09Nov 13 close+26.2%1M-30.4%6M-46.0%1Y-61.0%5Y-99.2%

Overview Financials Earnings Peers Projection Compare

Loading company

Every figure taken straight from a company’s own SEC filings, with the checks behind each grade shown — and whatever could not be found named rather than hidden.

Appearance

Product

Screener
Earnings calendar
Watchlists
Portfolios

Browse

Rankings
Free this week
Industries
Curated lists
Fund managers

Company

About
How the grade works
Glossary
Pricing
Contact

Legal

Terms of service
Privacy policy
Disclaimer
Cookie policy

InspectStocks describes businesses using their own reported figures. It is not investment advice and does not recommend buying or selling anything.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

XORTX Therapeutics Inc. (XRTX) latest earnings — what was reported — InspectStocks

XRTXXORTX Therapeutics Inc.$1.09Nov 13 close+26.2%1M-30.4%6M-46.0%1Y-61.0%5Y-99.2%

Compare

Overview Financials Earnings Peers Projection Compare

XORTX Therapeutics Inc.

XRTX · Nasdaq

Not rated

Compare

$1.09+26.2%Nov 13 close

Reported results on November 13, 2026; they are not in these figures yet.

Figures through December 31, 2025, from the 20-F filed March 20, 2026

Past performance

1W: +19.2%
1M: -30.4%
3M: -49.7%
6M: -46.0%
1Y: -61.0%
5Y: -99.2%

We hold no quarterly figures or earnings release for XORTX Therapeutics Inc. yet. Releases are read from a company’s Item 2.02 8-K or, for a foreign filer, the 6-K that carries its results.

Earnings calls

New

The latest call

Fetching

XORTX Therapeutics Inc. reported on November 13, 2026. We are fetching the call transcript; its summary follows once the transcript is in.